BR100 Increased By (0.04%)
BR30 Increased By (0.49%)
KSE100 Increased By (0.29%)
KSE30 Increased By (0.4%)
AGHA 6.44 Increased By ▲ 0.12 (1.9%)
BECO 4.37 Increased By ▲ 0.10 (2.34%)
BML 62.50 Increased By ▲ 0.05 (0.08%)
BOP 31.45 Increased By ▲ 0.22 (0.7%)
CNERGY 11.69 Increased By ▲ 0.10 (0.86%)
CSIL 5.81 Increased By ▲ 0.09 (1.57%)
FCCL 60.62 Decreased By ▼ -0.92 (-1.49%)
FFL 14.75 Decreased By ▼ -0.27 (-1.8%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.94 Increased By ▲ 0.38 (6.83%)
LOTCHEM 24.66 Decreased By ▼ -0.02 (-0.08%)
MLCF 103.05 Decreased By ▼ -1.03 (-0.99%)
NBP 173.25 Decreased By ▼ -2.03 (-1.16%)
NCPL 52.50 Decreased By ▼ -0.27 (-0.51%)
NPL 53.95 Decreased By ▼ -0.17 (-0.31%)
OGDC 316.80 Increased By ▲ 3.41 (1.09%)
PACE 9.25 Increased By ▲ 0.05 (0.54%)
PAEL 35.61 Decreased By ▼ -0.19 (-0.53%)
PIBTL 13.67 Increased By ▲ 0.20 (1.48%)
PPL 226.02 Increased By ▲ 4.21 (1.9%)
PRL 80.79 Increased By ▲ 1.71 (2.16%)
PTC 46.87 Increased By ▲ 0.02 (0.04%)
SSGC 23.75 Decreased By ▼ -0.12 (-0.5%)
TBL 9.28 Decreased By ▼ -0.03 (-0.32%)
TELE 7.57 Increased By ▲ 0.18 (2.44%)
TPL 24.69 Decreased By ▼ -0.42 (-1.67%)
TPLP 12.90 Increased By ▲ 0.39 (3.12%)
TREET 25.87 Decreased By ▼ -0.38 (-1.45%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)
By

NEW DELHI: A hugely popular Indian guru touting herbal remedies as a $7 cure for coronavirus was told by the government Tuesday that he needed to prove his claims before further marketing.

Baba Ramdev, a supporter of Prime Minister Narendra Modi, said the remedy would be available from next week through his lucrative Patanjali Ayurved company, claiming it was 100 percent successful on nearly 300 test patients.

The ubiquitous company is worth several hundred million dollars, selling everything from toothpaste to jeans. It is a major player in a vast Indian consumer goods market of 1.3 billion people.

Speaking at his company's headquarters in Haridwar, saffron-robed Ramdev said that "Coronil" and "Swasari" could cure coronavirus in a week.

Comments

Comments are closed for this article.